GAMMA Investing LLC Invests $768,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAMMA Investing LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,277 shares of the medical equipment provider’s stock, valued at approximately $768,000.

Other hedge funds also recently made changes to their positions in the company. OFI Invest Asset Management bought a new position in shares of Intuitive Surgical during the third quarter worth approximately $25,000. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC increased its holdings in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC bought a new position in shares of Intuitive Surgical during the third quarter worth approximately $28,000. Finally, Stone House Investment Management LLC boosted its position in shares of Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Piper Sandler increased their price target on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research report on Friday, January 19th. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Citigroup raised their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, BTIG Research raised their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $396.17.

Insider Activity

In other news, EVP Robert Desantis sold 20,296 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $393.80, for a total value of $7,992,564.80. Following the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,168,656.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the sale, the executive vice president now directly owns 5,507 shares in the company, valued at approximately $2,168,656.60. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 over the last quarter. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 2.2 %

Shares of NASDAQ ISRG traded up $8.15 during midday trading on Tuesday, hitting $377.08. The company’s stock had a trading volume of 1,836,588 shares, compared to its average volume of 1,677,112. The stock has a fifty day moving average price of $386.57 and a 200 day moving average price of $344.41. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The firm has a market capitalization of $133.66 billion, a price-to-earnings ratio of 68.22, a P/E/G ratio of 5.69 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the firm posted $1.00 earnings per share. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.